FDA cites major generic maker for keeping records in trash bags; pharma's latest hires and departures

Taking stock of the drug industry, from the lab to the medicine chest

March 3, 2023 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

JEAN-FRANCOIS MONIER/AFP/Getty Images STAT+ | As a U.S. agency denies permits to import monkeys for research, industry starts pushing back A trade group says restrictions on the import of monkeys used in research could "significantly slow the U.S. biopharmaceutical pipeline." By Ed Silverman STAT+ | FDA cites Cipla for placing important manufacturing records in the trash India has been a source of regulatory anxiety for years, in fact, and the FDA has attempted to bolster inspections. By Ed Silverman STAT+ | Ahead of genome summit in London, questions linger about CRISPR baby scandal The organizers of the genome summit are still grappling with the fallout of the 2018 CRISPR baby scandal and the ethical debate it ignited. By Megan Molteni Alex Hogan/STAT STAT+ | Up and down the ladder: The latest comings and goings From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry. By Ed Silverman STAT+ | The other way the government is privatizing Medicare This year, Medicare launched a new type of accountable care organization with a structure that looks a lot like Medicare Advantage. By John Wilkerson Opinion: How physician wellness programs keep doctors captive Wellness programs put the onus of resolving burnout on individual physicians. That's wrong, especially since these programs don't work. By Mark G. Shrime

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser